Antiemetic Prophylaxis with Fosaprepitant and 5-HT(3)-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

BACKGROUND: High-dose myeloablative conditioning prior to autologous hematopoietic stem cell transplantation (autoHSCT) in pediatric patients is usually highly emetogenic. The antiemetic neurokinin-1 receptor antagonist fosaprepitant was safe and effective in children receiving highly emetogenic che...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabanillas Stanchi, Karin Melanie, Willier, Semjon, Vek, Julia, Schlegel, Patrick, Queudeville, Manon, Rieflin, Nora, Klaus, Veronika, Gansel, Melanie, Rupprecht, Joachim Vincent, Flaadt, Tim, Binder, Vera, Feuchtinger, Tobias, Lang, Peter, Handgretinger, Rupert, Döring, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524181/
https://www.ncbi.nlm.nih.gov/pubmed/33061297
http://dx.doi.org/10.2147/DDDT.S260887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524181/
https://www.ncbi.nlm.nih.gov/pubmed/33061297
http://dx.doi.org/10.2147/DDDT.S260887

Ejemplares similares